Tiotropium in asthma [1]

New England Journal of Medicine

Volumn 367, Issue 26, 2012, Pages 2552-2553

  Lipworth, Brian ^a   Manoharan, Arvind ^a   Short, Philip ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; NITRIC OXIDE; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; SCOPOLAMINE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BREATHING MUSCLE; BRONCHODILATATION; BRONCHUS REACTIVITY; CHOLINERGIC TRANSMISSION; DISEASE EXACERBATION; DRUG POTENTIATION; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RISK REDUCTION; TREATMENT OUTCOME; FEMALE; MALE; NOTE;

ASTHMA; BRONCHODILATOR AGENTS; FEMALE; HUMANS; MALE; SCOPOLAMINE DERIVATIVES;

EID: 84871709090     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1213076     Document Type: Letter

References (5)

1. Kerstjens HAM, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med 2012;367:1198-207.
2. Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J 1999;14:23-7.
3. Britton J, Hanley SP, Garrett HV, Hadfield JW, Tattersfield AE. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax 1988;43:300-5.
4. Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med 2007;101:1218-28.
5. Barnes PJ. Muscarinic autoreceptors in airways: their possible role in airway disease. Chest 1989;96:1220-1.